The global outbreak of COVID-19 has disrupted many aspects of healthcare delivery - cancer prevention and care are no exception [1]. The pandemic has exposed the vulnerability of our healthcare systems, our societies, and our health, as well as exacerbated inequalities within and between European countries. It has also cast a spotlight on the vulnerability of people living with cancer.